(Q35146347)
Statements
Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer (English)
Fang Yang
Ling Ma
Yuchen Fan
Bing He
Qihua He
Xueqing Wang